Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 1/20 | 0.40 |
| ▸ | OXTR | P30559 | 1/20 | 0.40 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.40 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.38 |
| ▸ | GCK | P35557 | 1/20 | 0.37 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.37 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.36 |
| ▸ | TUBB | P07437 | 1/20 | 0.36 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.36 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.36 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.36 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.36 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.36 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.36 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.36 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.36 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.36 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.36 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.36 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26697786 | 1.00 | AVPR2 (0.40) | AVPR2OXTRAVPR1ATAS2R14GCK | |
| SCHEMBL26871192 | 0.93 | AVPR2 (0.40) | AVPR2OXTRAVPR1ATAS2R14GCK | |
| SCHEMBL25228488 | 0.92 | KMT2A (0.41) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| SCHEMBL30287347 | 0.92 | KMT2A (0.41) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| SCHEMBL25275117 | 0.84 | OXTR (0.38) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| SCHEMBL30287307 | 0.84 | OXTR (0.38) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| Padoprazan SCHEMBL25225599 | 0.82 | AVPR2 (0.39) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| Padoprazan SCHEMBL30250197 | 0.82 | AVPR2 (0.39) | AVPR2OXTRAVPR1AGCKEPHB4 | |
| Padoprazan SCHEMBL30985953 | 0.81 | AVPR2 (0.36) | AVPR2OXTRAVPR1ATAS2R14GCK | |
| SCHEMBL30287336 | 0.81 | KMT2A (0.38) | GCKMEN1KMT2ASMN1; SMN2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084026-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ILDONG PHARMACEUTICAL CO LTD (KR) | 2025-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084026-A1 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | ABCG2, SLC7A1, SLC34A1 | AVPR2 303/4885OXTR 3536/4885AVPR1A 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.